U.S. STOCKS Bausch + Lomb, Alcoa, crypto stocks
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
The main U.S. stock indexes were set for a mixed open on Monday as caution set in on Wall Street ahead of the Federal Reserve's pivotal monetary policy decision, due later in the week, with a majority of traders pricing in a steep cut in borrowing costs. .N
At 9:04 ET, Dow e-minis 1YMc1 were up 0.21% at 41,513. S&P 500 e-minis ESc1 were down 0.08% at 5,625.5, while Nasdaq 100 e-minis NQc1 were down 0.48% at 19,436.
The top three NYSE percentage gainers premarket .PRPG.NQ:
** V2X <VVX.N>, up 22.3%
** Bausch + Lomb <BLCO.N>, up 17.6%
** Sos <SOS.N>, up 10.0%
The top three NYSE percentage losers premarket .PRPL.NQ:
** Spire Global <SPIR.N>, down 14.9%
** Container Store Group <TCS.N>, down 7.1%
** Farmland Partners <FPI.N>, down 6.6%
The top Nasdaq percentage gainer premarket .PRPG.O:
** Nucana Plc <NCNA.O>, up 152.4%
** Intel INTC.O: up 2.3% premarket
BUZZ - Gains on report of qualifying for $3.5 bln grant to make chips for US military nL4N3KY0DA
** Bausch + Lomb BLCO.N: up 17.6% premarket
BUZZ - Gains after report co exploring sale nL4N3KY0FB
** Coinbase Global COIN.O: down 2.4% premarket ** Bitfarms BITF.O: down 2.9% premarket ** Riot Platforms RIOT.O: down 2.2% premarket
** Hut 8 Mining HUT.O: down 2.1% premarket
BUZZ - Crypto stocks down on weakness in bitcoin nL4N3KY0FF
** Alcoa AA.N: up 4.2% premarket
BUZZ - Rises after sale of $1.1 bln stake in Ma’aden joint venture nL4N3KY0HA
** Trump Media & Technology Group DJT.O: up 1.8% premarket
BUZZ - Stretches gains after second assassination attempt on Trump nL1N3KY0AH
** Colgate-Palmolive CL.N: down 1.4% premarket
BUZZ - Down after Wells Fargo cuts rating nL4N3KY0IL
** Zillow Group ZG.O: up 3.7% premarket
BUZZ - Rises; Wedbush upgrades to 'outperform', lifts PT nL4N3KY0IX
** Nuvalent NUVL.O: up 22.1% premarket
BUZZ - Gains after brokerages raise PT on promising cancer therapy data nL4N3KY0N6
** Zentalis Pharmaceuticals ZNTL.O: up 44.4% premarket
BUZZ - Gains as FDA lifts partial clinical hold on cancer drug studies
nL4N3KY0KO
** Upstart Holdings UPST.O: down 7.1% premarket
BUZZ - Slides on planned $300 mln convertible debt deal nL1N3KY0E8
** Builders FirstSource BLDR.N: up 2.9% premarket
BUZZ - Rises after Truist upgrade nL4N3KY0OR
(Compiled by Rajarshi Roy and Neil J Kanatt)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
